The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy
Main Article Content
Keywords
N/A
Abstract
N/A
References
1. Del-Río Camacho G, Montes Arjona AM, Fernández-Cantalejo Padial J, Rodríguez Catalán J. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollenallergic children. Allergol Immunopathol. 2018;46:552-6.
2. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosign MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67:709-11.
3. Ciprandi G, Scala E, Ariano R. Phleum pratense molecular pattern across Italy. Eur Annals Allergy Clin Immunol. 2017;49:176-80.
4. Ciprandi G, Silvestri M, Tosca MA. Combo-VAS: an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practice. Annals Allegy Asthma Immunol. 2018;121:504-6.
2. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosign MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67:709-11.
3. Ciprandi G, Scala E, Ariano R. Phleum pratense molecular pattern across Italy. Eur Annals Allergy Clin Immunol. 2017;49:176-80.
4. Ciprandi G, Silvestri M, Tosca MA. Combo-VAS: an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practice. Annals Allegy Asthma Immunol. 2018;121:504-6.
